(Z)-9,9-Dimethoxynon-3-ene
Common Name: |
(Z)-9,9-Dimethoxynon-3-ene |
IUPAC Name: |
(Z)-9,9-dimethoxynon-3-ene |
Molecular Formula: |
C11H22O2 |
SMILES: |
CCC=CCCCCC(OC)OC |
Inchi: |
1S/C11H22O2/c1-4-5-6-7-8-9-10-11(12-2)13-3/h5-6,11H,4,7-10H2,1-3H3/b6-5- |
Inchi Key: |
UVCRVXVBFFMDFR-WAYWQWQTSA-N |
Cas No: |
68555-53-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
186.29 |
Mass (g/mol) |
186.162 |
Molar Refractivity |
56.69 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
8 |
Rings |
|
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
233.00 to 234.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.084 |
Vapor Density (Air =1) |
>1 |
Fraction Csp3 |
0.82 |
LogP |
3.132 |
iLOGP |
3.27 |
XLOGP3 |
3.12 |
WLOGP |
3.13 |
MLOGP |
2.47 |
ESOL Log S |
-2.43 |
ESOL Solubility (mg/ml) |
0.688 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.18 |
Ali Solubility (mg/ml) |
0.12 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.69 |
Silicos-IT Solubility (mg/ml) |
0.38 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.22 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.06 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.383 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |